Organic Active Ingredients TRIZ Cases

Iron amino acid chelates replace complex hemoglobin to eliminate toxicity while maintaining effective oxygen delivery.

A crystalline polymorph of a benzimidazole derivative inhibits histone deacetylase activity to treat cancer.

Pyridine[3,4-b]pyrazinone compounds inhibit phosphodiesterase type 5 to manage hypertension via nitric oxide potentiation.

Colonization enhancers stimulate transformed anaerobic microorganisms at disease sites, reducing required doses and minimizing horizontal gene transfer risks.

VX-745 inhibits cytokine signaling to restore function beyond the acute treatment window.

Hydrophobic nanoparticles embedded in liposome membranes promote inverted hexagonal phase formation, enabling efficient endosomal escape of therapeutic cargo.

High DHA supplements delay ovarian aging to enhance fertility outcomes in advanced maternal age.

Anti-transferrin receptor 1 antibodies covalently link to oligonucleotides to deliver molecular payloads into muscle cells.

Non-digestible polymer particles adsorb harmful gut metabolites, preventing systemic absorption and alleviating neurological symptoms.

Solid dispersion of micronized fenofibrate in hydrophilic carrier matrix overcomes low water solubility to boost plasma concentration.

A cyclic amine derivative acts as an analgesic agent for treating neuropathic pain and fibromyalgia syndrome.

Aseptic size exclusion filtration yields live, infectious Plasmodium sporozoites with high purity for vaccine compositions.

Chemically modified siRNA oligonucleotides down-regulate p53 expression to attenuate kidney damage.

siRNA-lipid particles silence SMAD4 gene expression, regulating iron metabolism without oxidative harm from infused iron compounds.

Predicts TUSC2 therapy response using apoptosis markers to overcome intratumoral delivery limits and target systemic metastases.

Reflux heating of perindopril arginine salt in toluene or acetonitrile yields a defined beta crystalline form.

Transforming 25(OH)D concentration into a C24CPR ratio resolves the contradiction between measurement precision and reliability in vitamin D status assessment.

Intravenous allogenic mesenchymal stromal cells reduce inflammatory markers and control pulmonary artery pressure to resolve coagulation dysfunction.

Delayed release coating prevents immediate gastric dissolution of naltrexone, reducing hyperalgesia and nausea while maintaining therapeutic efficacy.

A segmented oral dosage form uses a barrier layer to separate immediate release and controlled release drug components.

A green chemistry process for ribociclib preparation uses environmentally friendly solvents to produce novel crystalline forms.

A 4EBP-activating agent normalizes cap-dependent translation in target brain cells, reducing seizure frequency without invasive surgery.

2-Azaspiro[3.3]heptane derivatives selectively antagonize the M4 receptor, reducing extrapyramidal symptoms without cognitive impairment.

Tri-substituted aryl compounds inhibit the PI3K-AKT-mTOR pathway to clear toxic protein aggregates in neurodegenerative disorders.

Replacing complex monoclonal antibodies with small molecule lactone and lactam inhibitors restores T cell activation by blocking PD-1/PD-L1 interactions.

Small molecule compounds modulate nucleic acid splicing by binding to specific proteins, addressing limited regulation of alternative splicing patterns.

A hydrophobic release lotion uses humectants and surfactants to deliver Cannabaceae derivatives via controlled diffusion.

Segmented cationic polymer films enable distinct temporal release profiles for nucleic acids without complex device structures.

Fused tetracyclic compounds inhibit HBV DNA replication and HBsAg production, addressing limitations of existing interferon and nucleoside analogue therapies.

Segmenting prebiotic fiber, probiotics, and postbiotics via intermediaries resolves synergy identification bottlenecks while improving cognitive performance.

Segmented controlled release pellets deliver high dosages in swallowable units, resolving size constraints for geriatric and pediatric patients.

Merging the alkylating agent Tinostamustine with Nivolumab improves survival outcomes while minimizing adverse events in advanced melanoma therapy.

Quercetin composition combined with vitamins B3, C, and folate inhibits Zika virus replication while reducing drug side effects.

Combining BI853520 with chemotherapeutic drugs enhances antitumor activity through synergistic effects.

Controlled crystallization yields stable PQQ sodium salt crystals with reduced hygroscopicity, improving pharmaceutical processing.

Carbonyl erastin analogs deplete glutathione and inhibit system xc− to selectively kill tumor cells with oncogenic RAS mutations.

Formula I pyrazolo[3,4-b]pyrazine compounds inhibit SHP2 phosphatase activity to reduce disease severity in cancer and Noonan syndrome.

Modulating APRIL signaling enhances brown fat thermogenesis via UCP-1 expression to address obesity and metabolic syndrome risks.

Zinc oxide nanoparticles adsorb sulfasalazine to prevent premature metabolic conversion and reduce adverse effects from 5-ASA formation.

Hydroxypropyl-beta-cyclodextrin improves melatonin solubility in this herbal composition, addressing bioavailability challenges in intranasal delivery.

Topical pentacyclic triterpenes reduce MMP-9 expression and oxidative stress, offering a low-cost alternative to complex vitiligo therapies.

Distinct rifaximin polymorphs reduce systemic absorption and bacterial resistance while maintaining therapeutic efficacy in the gut.

Oral composition with highly active bile salt hydrolase bacteria degrades intestinal bile salts to lower serum lipid levels.

Intermittent BRAF kinase inhibitor dosing schedules delay tumor regrowth by exploiting the selective disadvantage of resistant cells during drug-free intervals.

A pharmaceutical composition comprising rubeola virus, histamine, and collagen for treating Ehlers-Danlos syndrome.

Hyaluronic acid replaces albumin in peptide-polynucleotide formulations to resolve the trade-off between nanoparticle size uniformity and therapeutic potency.